本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Karyopharm Therapeutics Inc.

1.70
0.0000
成交量:43.54萬
成交額:74.33萬
市值:3,852.70萬
市盈率:-0.13
高:1.77
開:1.75
低:1.66
收:1.70
52周最高:10.99
52周最低:1.24
股本:2,266.29萬
流通股本:1,577.42萬
量比:0.39
換手率:2.76%
股息:- -
股息率:- -
每股收益(TTM):-13.0816
每股收益(LYR):-17.9300
淨資產收益率:-891.05%
總資產收益率:-47.61%
市淨率:-0.12
市盈率(LYR):-0.09

資料載入中...

2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

重要事件披露

Current report, items 2.02 and 9.01
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

重要事件披露

Current report, item 5.02
2020/02/06

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/09

重要事件披露

Current report, items 8.01 and 9.01
2019/11/18

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/04

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/04

重要事件披露

Current report, items 2.02 and 9.01
2019/09/16

重要事件披露

Current report, items 1.01 and 9.01